Questions discussed in this category
Would your considerations change for a man vs a woman?
Would you consider testosterone therapy if he is otherwise asymptomatic?
Additional risk factors could be family history of VTE or thrombophilia, such as antithrombin deficiency.
Is patch or gel HRT with ASA prophylaxis a reasonable option after counseling? Or do you add a prophylactic DOAC?
No prior thrombosis; no family history of thrombosis. As per endocrine, the only useful therapy for the osteoporosis is estrogen.
The patient has no personal history of VTE, but has positive family history of VTE.
Any prophylactic anticoagulation options?
How would manage...
For pts w/ eGFR between 30-60
Recommendations in guidelines are discordant (ASCO vs NCCN vs UptoDate).
185062138020629211292057414321157551656314292139031197387119822
Papers discussed in this category
BMJ, 2008 May 20
Circulation,
Cancer,
Blood, 2013-10-24
The Lancet. Oncology, 2011-08
The Lancet. Oncology, 2018-03
Post reproductive health, 2022 Dec 27
Blood advances, 2017 Dec 21
Journal of thrombosis and haemostasis : JTH, 2019 Sep 13
The Journal of clinical endocrinology and metabolism, 2024 Jan 18
Journal of the Endocrine Society, 2022 Dec 02
Diagnostics (Basel, Switzerland), 2021 Apr 20
The Journal of clinical endocrinology and metabolism, 2018 May 01
The Journal of urology, 2022 Jan 20
Haematologica, 2009 Oct 14
American journal of hematology, 2023 Jul 20